Home » Advocacy » Letters, Testimony & Comments

Letters, Testimony & Comments

Testimony before the Texas House
April 11, 2005
Testimony of the Biotechnology Industry Organization (BIO) before the Texas House of Representatives State Affairs Committee, regarding House Bill 1929: The Use of Human Cells and Tissue. (April 11, 2005)
Comments on Docket No. 2005D-0022 , International Conference on Harmonisation; Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
April 11, 2005
BIO Testimony regarding Oregan Senate Bill 570
April 8, 2005
Testimony to the Oregon Senate Environment & Land Use Committee regarding The Oregon Genetically Engineered Pharmaceutical and Industrial Crop Act
BIO Commends New Effort to Bring Biomedical Miracles To Developing Nations
April 7, 2005
Squaring our Shoulders Against Neglected Diseases: Advanced Purchase Commitment Plan an Important Step
Comments on FDA Draft Guidance on Using a Centralized IRB Process
March 27, 2005
The Biotechnology Industry Organization (“BIO”) is pleased to have the opportunity to comment on the Food and Drug Administration’s (“FDA’s” or the “agency’s”) draft guidance on using a...
Comments on Docket No. 2004N-0355, Scientific considerations Related to Developing follow-on Protein Products
March 16, 2005
BIO Comments on OECD Guidelines
March 11, 2005
Testimony before the Maryland House
March 3, 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland House Health and Government Operations Committee Regarding House Bill 885 The Human Cloning Prohibition Act of 2005 Mr. Chairman and members of the committee, thank...
Testimony before the Maryland House
March 3, 2005
Testimony of the Biotechnology Industry Organization (BIO) before the Maryland House Health and Government Operations Committee opposing House Bill 885: The Human Cloning Prohibition Act of 2005. (March 3, 2005)
Testimony before the Maryland Senate
March 2, 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland Senate Education, Health and Environmental Affairs Committee Regarding Senate Bill 751 The Maryland Stem Cell Research Act of 2005 Madam Chair and members for the...
Testimony before the Maryland Senate
March 2, 2005
Testimony of the Biotechnology Industry Organization (BIO) before the Maryland Senate Education, Health and Environmental Affairs Committee in support of Senate Bill 751: The Maryland Stem Cell Research Act of 2005. (March 2, 2005)
EMEA's Draft Guideline on Similar Biological Medicinal Products
February 28, 2005
Comments by BIO; CHMP/437/04
Oral Statement Before the Advisory Panel on Ambulatory Payment Classification Groups
February 23, 2005
Dr. Hambrick and members of the APC Advisory Panel, thank you for the opportunity to be here today. Unfortunately, Terry Ghio was unable to testify. My name is Beth Roberts, and I am a partner at Hogan & Hartson and serve as outside counsel to...
Merck v. Integra
February 22, 2005
2005 Special 301 Submission
February 11, 2005
Hawaii Senate Bill 1036
February 10, 2005
Testimony to oppose Hawaii Senate Bill 1036 which "provides strict liability for injuries caused by biotech products from plant sources" (February 10, 2005).
Hawaii Senate Bills 1425 and 1692
February 10, 2005
Testimony to oppose Senate Bills 1425 and 1692 which relate the regulation of bioprospecting (February 10, 2005).
Hawaii Senate Bills 644, 645, 647, 649, 1037, 1847
February 10, 2005
Testimony to oppose Senate Bills 644, 645, 647, 649, 1037, 1847 which propose to restrict or ban or otherwise regulate various aspects of agricultural biotechnology (February 10, 2005).
BIO Testimony in opposition to Vermont Senate Bill 18
February 9, 2005
to place liability on manufacturers for "claims and damages resulting from the use, according to the label and directions for use, of genetically engineered seeds and plant parts." (February 9, 2005).
BIO Letter to Washington Representative Shay Schual-Berke, M.D.
January 31, 2005
Supporting House Bill 1268, which would preserve therapeutic cloning research in the state